Fosamax Lawsuit (MDL-2243) — Eligibility, Settlement Updates, and How to File

The fosamax lawsuit is a federal legal action against drugmaker Merck. It involves the osteoporosis medication Fosamax, known generically as alendronate sodium. Thousands of patients say the drug caused serious bone injuries. These include atypical femur fractures and jawbone damage. The claims are consolidated in a federal court in New Jersey. This page explains what the litigation covers. It also explains who may qualify and how to file. Always speak with a licensed attorney about your own situation.

Case Timeline

Last checked: September 03, 2026

Advertisement

  • April 01, 2026 (Case Status): The MDL had 561 actions pending out of 1,293 total cases filed, with the reinstated cases positioned for potential bellwether trials. (Court Record)
  • February 19, 2026: Supreme Court blocks bid to sue Merck over Fosamax bone fractures (abcnews.com)
  • February 04, 2026: FDA Fosamax Warnings- FDA Issues Warnings for Osteoporosis Drug Fosamax (ClassAction.org)
  • June 18, 2025: Fosamax Femur Fracture Lawsuits Set To Move Forward After Supreme Court Refuses Appeal (AboutLawsuits.com)
  • June 17, 2025: Hundreds of Revived Fosamax Lawsuits Allowed to Move Forward as U.S. High Court Denies Merck’s Bid for Appeal (Law.com)
  • June 16, 2025 (Ruling): The U.S. Supreme Court denied Merck’s petition for certiorari, leaving the Third Circuit’s reinstatement in place and returning the cases to Judge Karen Williams for further proceedings. (Court Record)
  • September 20, 2024: Court revives more than 500 lawsuits over Fosamax femur fracture risk (Reuters)
  • September 20, 2024 (Ruling): The Third Circuit reversed, holding the FDA’s Complete Response Letter was not a final action that preempted state-law claims, reinstating more than 500 dismissed Fosamax lawsuits. (Court Record)
  • March 23, 2022 (Ruling): On remand, Judge Freda Wolfson again granted Merck summary judgment, dismissing the cases as preempted based on the FDA’s rejection of Merck’s proposed labeling change. (Court Record)
  • May 20, 2019 (Ruling): The U.S. Supreme Court, in Merck v. Albrecht, vacated the dismissal and held that whether a failure-to-warn claim is preempted is a question of law for the judge, remanding the MDL for reconsideration. (Court Record)
  • What Is the Fosamax Lawsuit About?

    Fosamax is a bisphosphonate drug. Doctors prescribe it to slow bone loss in people with osteoporosis. It works by reducing how quickly bone breaks down. However, plaintiffs say long-term use created a dangerous side effect. The medication may make certain bones brittle over time.

    The core injury is the atypical femur fracture. This is a break in the thigh bone. It often happens with little or no trauma. For example, some patients report fractures from simply standing or walking. A second injury is osteonecrosis of the jaw. This condition, called ONJ, involves jawbone tissue dying.

    The fosamax lawsuit argues that Merck failed to warn patients and doctors. Plaintiffs claim the company knew about these risks. They say the warning labels came too late or were too weak. The U.S. Food and Drug Administration later required stronger warnings for this drug class. As a result, many patients pursued legal claims for their injuries.

    MDL Case Status and Key Facts

    MDL Detail Current Data
    MDL Number MDL-2243
    Pending Cases 550
    Presiding Judge Karen M. Williams
    Federal District NJ
    Data Source U.S. Judicial Panel on Multidistrict Litigation
    Last Updated August 03, 2026

    These cases are grouped in a multidistrict litigation, or MDL. An MDL combines similar federal lawsuits before one judge. This makes pretrial work more efficient. It does not merge the cases into a single class action. Each plaintiff keeps a separate claim.

    Detail Information
    MDL Number MDL-2243
    Case Name In re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II)
    Presiding Judge Hon. Karen M. Williams
    Federal District U.S. District Court, District of New Jersey
    Approximate Pending Cases About 550–560 (2026)
    Primary Defendant Merck & Co.
    Bellwether Trials Earlier femur-fracture bellwethers held; no new dates set for 2026

    Judge Karen M. Williams oversees the litigation. The docket has moved through several major stages. Courts once dismissed many femur fracture cases on legal grounds. However, a federal appeals court later revived them. The U.S. Supreme Court declined to review that ruling in 2025.

    As a result, the judge reinstated cases not already dismissed with prejudice. In most cases, the parties are now sorting out which claims remain active. The fosamax lawsuit docket held roughly 550 pending actions in 2026. More than half of all filed cases have resolved over the years.

    Who Qualifies for the Fosamax Lawsuit?

    Eligibility depends on your history with the drug. Typically, qualifying plaintiffs took Fosamax or generic alendronate. Many used it for three years or longer. Long-term use is a common thread in these claims.

    The injury must generally match the known risks. For example, an atypical femur fracture is a strong basis. Osteonecrosis of the jaw may also qualify. In most cases, the fracture happened with little or no major impact. A qualifying injury usually requires medical documentation.

    Evidence matters a great deal in a fosamax lawsuit. Helpful records include prescription histories and pharmacy receipts. X-rays and surgical reports also help prove the injury. Dental records support jaw-related claims. An attorney can review whether your records fit the criteria. Time limits also apply, so acting promptly is important.

    How to File a Fosamax Lawsuit Claim

    Filing starts with a legal consultation. Look for a lawyer who handles pharmaceutical injury cases. Many offer free case reviews. Typically, they work on a contingency fee. That means you pay nothing unless you recover money.

    Next, your attorney gathers your medical and pharmacy records. They confirm your Fosamax use and your injury. If your case fits, they file it in the MDL. Each plaintiff usually completes a plaintiff fact sheet. This document details your health history and drug use.

    📨 Get Free Mass Tort Guides Alerts

    Free · No spam · Unsubscribe anytime

    Deadlines are critical to any fosamax lawsuit. Every state sets a statute of limitations. This is the window to file after an injury or discovery. Missing it can end your claim permanently. However, the exact deadline varies by state and situation. For that reason, consult a licensed attorney quickly to protect your rights.

    Settlement Updates and What to Expect

    Settlement history in this litigation is mixed. Merck previously resolved a large group of jaw injury claims. That resolution covered many osteonecrosis cases. However, it did not settle the femur fracture claims. Those claims followed a separate legal path.

    Bellwether trials help both sides gauge value. A bellwether is a test case tried before the others. Merck won an early federal bellwether involving a femur fracture. Such outcomes shape settlement talks. As a result, no broad femur-fracture settlement framework exists yet in 2026.

    Payout amounts vary widely and are never guaranteed. Compensation depends on injury severity and evidence strength. Medical costs, lost income, and pain all factor in. Do not expect a fixed figure from any fosamax lawsuit. You may qualify for compensation, but every case is different. A licensed attorney can give a realistic assessment of your claim.

    State-by-State Considerations

    The MDL is federal, but state law still matters. Each claim usually follows the law of the plaintiff’s home state. State tort reform rules can affect damages and deadlines. For example, some states cap certain non-economic damages. Others have shorter filing windows.

    Plaintiffs come from across the country. States with large older populations often see more claims. These include California, Florida, Texas, New York, and Pennsylvania. However, a fosamax lawsuit can arise anywhere the drug was used. Check your state guide and consult a local attorney about specific rules.

    Frequently Asked Questions

    Is Fosamax still on the market in 2026?

    Yes, alendronate remains available by prescription. It carries updated warnings about rare bone risks. Doctors still weigh its benefits against those risks for each patient.

    What injuries can support a fosamax lawsuit?

    The main injuries are atypical femur fractures and osteonecrosis of the jaw. Both must be documented in your medical records. An attorney can confirm whether your injury qualifies.

    How much does it cost to hire a lawyer?

    Most attorneys in these cases work on contingency. You typically pay nothing upfront. Fees usually come from any recovery you receive, so ask about terms first.

    Check If You May Qualify

    Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.

    Official Sources & Resources

    For verified mass tort and MDL information:

    Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

    Related Guides

    Going through divorce too? Compare state laws at Divorce Help Guide. Affected by a recalled drug as a Medicare patient? See Medicare Cover Guide. Just diagnosed with a serious illness? Compare life insurance at Life Insure Guide. PFAS in your water? Check homeowners coverage at Home Insure Guide.